Sensitive enzyme-linked immunosorbent assay for adult T-cell leukemia- derived factor and normal value measurement

Journal of Clinical Laboratory Analysis

Volumn 10, Issue 5, 1996, Pages 257-261

  Kogaki, Hiroyuki ^a   Fujiwara, Yuko ^a   Yoshiki, Akemi ^a   Kitajima, Sachiko ^a   Tanimoto, Tetsuji ^a   Mitsui, Akira ^b   Shimamura, Toshiro ^b   Hamuro, Junji ^b   Ashihara, Yoshihiro ^a  

^a FUJIREBIO INC   (Japan)

^b AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOKINE; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BLOOD LEVEL; CROSS REACTION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; MALE; NORMAL HUMAN; NORMAL VALUE;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; CROSS REACTIONS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM PROTEINS; REFERENCE VALUES;

EID: 0029832997     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1996)10:5<257::AID-JCLA5>3.0.CO;2-5     Document Type: Article

References (31)

1. Teshigawara K, Maeda M, Nishino K, NikaidoT, Uchiyama T, Tsudo M, Wano Y, Yodoi J: Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J Mol Cell Immunol 2:17-26, 1985.
2. Okada M, Maeda M, Tagaya Y, Taniguchi Y, Teshigawara K, Yoshiki T, Diamantstein T, Smith KA, Uchiyama T, Honjo T, Yodoi J: TCGF(IL-2)-receptor including factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL-2 receptor expression of HTLV-I(+) T cell lines. J Immunol 135:3995-4003, 1985.
3. Tagaya Y, Okada M, Sugie K, Kasahara T, Kondo N, Hamuro J, Matushima K, Dinarello CA, Yodoi J: IL-2 receptor (p55)/Tac-inducing factor: Purification and characterization of adult T cell leukemia-derived factor. J Immunol 140:2614-2620, 1988.
4. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, Yodoi J: ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to trioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8:757-764, 1989.
5. Wollman EE, Auriol, Rimsky L, Shaw A, Jacquot J-P, Wingfield P, Graber P, Dessarps F, Robin P, Galibert F, Bertoglio J, Fradelizi D: Cloning and expression of cDNA from human thioredoxin. J Biol Chem 263:15506-15512, 1988.
6. Holmgren A: Thioredoxin. Annu Rev Biochem 54:237-271, 1985.
7. Johnson RS, Mathews WR, Biemann K, Hopper S: Amino acid sequence of thioredoxin isolated from rabbit bone marrow determined by tandem mass spectrometry. J Biol Chem 263:9589-9597, 1988.
8. Wakasugi H, Rimsky L, Mahe Y, Kamel AM, Fradelizi D, Tursz T, Bertoglio J: Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Proc Natl Acad Sci USA 84:804-808, 1987.
9. Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, Tursz T: Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA 87:8282-8286, 1990.
10. Silberstein DS, Ali MH, Baker SL, David JR: Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide. J Immunol 143:979-988, 1989.
11. Grippo JF, Holmgren A, Paratt WB: Proof that the endogeneous, heatstable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem 260:93-97, 1985.
12. Mitsui A, Hirakawa T, Yodoi J: Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun 186:1220-1226, 1992.
13. Nakamura H, Masutani H, Tagaya Y, Yamauchi A, Inamoto T, Nanbu Y, Fujii S, Ozawa K, Yodoi J: Expression and growth-promoting effect of adult T-cell leukemia-derived factor. Cancer 69:2091-2097, 1992.
14. Masutani H, Naito M, Takahashi K, Hattori T, Koito A, Takatsuki K, Go T, Nakamura H. Fujii S, Yohsida Y, Okuma M, Yodoi J: Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HTV infection: Loss of ADF high-producer cells in lymphoid tissues of AIDS patients. AIDS Res Hum Retrovir 8:1707-1715, 1992.
15. Holmgren A: Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoarmide. J Biol Chem 254:9627-9632, 1979.
16. Kitaoka Y, Sorachi K, Nakamura H, Masutani H, Mitsui A, Kobayashi F, Mori T, Yodoi J: Detection of adult T-cell leukemia-derived factor/human thioredoxin in human serum. Immunol Lett 41:155-161, 1994.
17. Kitaoka Y, Yodoi J: ADF/thioredoxin. In Cell Technology Active Oxygen Experiments Protocol, [in Japanese], N Taniguchi, ed. Shujunsha, Tokyo, 1994, p 89-92.
18. Tagaya Y, Wagasugi H, Masutani H, Nakamura H, Iwata S, Mitsui A, Fujii S, Wakasugi N, Tursz T, Yodoi J: Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: Involvement of dithiol related reduction. Mol Immunol 27:1279-1289, 1990.
19. Gefter ML, Margulies DH, Scharff MD: A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Soma Cell Genet 3:231-236, 1977.
20. Nisonoff A. Rivers MM: Recombination of mixture of univalent antibody fragments of different specificity. Arch Biochem Biophys 93:460-464, 1961.
21. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77, 1959.
22. Nakane PK, Kawaoi A: Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem 22:1084-1091, 1974.
23. Hopper S, Johnson RS, Vath JE, Biemann K: Glutaredoxin from rabbit bone marrow. Purification, characterization, and amino acid sequence determined by tandem mass spectrometry. J Biol Chem 264:20438-20447, 1989.
24. Boniface JJ, Reichert LE Jr: Evidence for a novel thioredoxin-like catalytic property of gonadotropic hormones. Science 247:61-64, 1990.
25. Borth W, Scheer B, Urbansky A, Luger TA, Sottrup-Jensen L: Binding of IL-1β to alpha-macrogloblins and release by thioredoxin. J Immunol 145:3747-3754, 1990.
26. Silberstein DS, McDonough S, Minkoff MS, Balcewicz-Sablinska MK: Human eosinophil cytotoxicity-enhancing factor. Eosinophil-stimulating and dithiol reductase activities of biosynthetic (recombinant) species with COOH-terminal deletions. J Biol Chem 268:9138-9142, 1993.
27. Pastori RL, Zucker KE, Xing YY: Restoration of binding of oxidized transcription factor IIIA to 5S RNA by thioredoxin. Nucleic Acids Res 16:8797-8507, 1988.
28. Hentze MW, Rouault TA, Harford JB, Klausner RD: Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 244:357-359, 1989.
29. Storz G, Tartaglia LA, Ames BN: Transcriptional regulator of oxidative stress-inducible genes: Direct activation by oxidation. Science 248:189-194, 1990.
30. Abate C, Patel L, Rauscher III FJ, Curran T: Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157-1161, 1990.
31. Okamoto T, Ogiwara H, Hayashi T, Mitsui A, Kawabe T, Yodoi J: Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Immunology 4:811-819, 1992.